1. Repurposing Statins in Combination Therapy for effective ablation of metastatic breast cancer
   Rifat Aara, Neeha Sinai Borker, Jyothilakshmi Sajimon, Athul Krishnan R, Diya Aich, Debolina Das, Mohit Kumar Jolly, Jyothi S Prabhu, Radhika Nair
   (Corresponding author)
   June 2025, Advanced Therapeutics (Under review)
2. bioRxiv 2025.05.25.655937;
   Role of Intratumoral heterogeneity in metastatic progression and drug resistance.
   Neeha Sinai Borker , Jyothilakshmi Sajimon, Seemadri Subhadarshini, Rifat Aara, Mohit Kumar Jolly, Jyothi S Prabhu, Radhika Nair
   (Corresponding author)
   April 2025, Discover Oncology (Under review)
3. Fabrication of Mirror Image Nanopores at Molecular and Cellular Level
   Neilah Firzan CA*, Rifat Aara*, Kalyanashis Jana*, Sreelakshmi Radhakrishnan*, Mubeena S, Radhika Nair, Harsha Bajaj, Ulrich Kleinekathöfer, and Kozhinjampara R Mahendran
   ( * co first authors, CHG)
   January 2025, Nature Communications (Under review)
4. Phenotypic heterogeneity drives differential disease outcome in a mouse model of Triple Negative Breast Cancer
   Archana P. Thankamony, Sonny RamKomuth, Shikha T. Ramesh, Reshma Murali, Priyanka Chakraborty, Nitheesh Karthikeyan, Binitha Anu Varghese, Vishnu Sunil Jaikumar, Mohit Kumar Jolly, Alexander Swarbrick and Radhika Nair
   Front. Oncol. Sec. Cancer Molecular Targets and Therapeutics
   Volume 13 – 2023 | doi: 10.3389/fonc.2023.1230647
5. Unravelling the dangerous Duet between Cancer cell plasticity and drug resistance.
   Chatterjee, Namrata; Pulipaka, Bhavana ; Subbalakshmi, Ayalur Raghu ; Jolly, Mohit Kumar; Nair , Radhika
   July 2023, Computational and Systems Oncology;

        Google Scholar : Radhika Nair